Neurocrine Biosciences Inc.
NBIX | NASDAQ
$145.89
-$0.21 (-0.14%)
Nov 2, 2026, 2:12 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 705.5M | 668.6M | 478.6M | 428M | 348.3M | 305.8M | 341.3M | 385.9M | 339.2M | 369.7M | 249.7M | 191M | 176.4M | 64M | 154.5M | 58.2M | 12.2M | 71.4M | 89.6M | 444.8M | 364.7M | 402M |
Depreciation & Amortization | 47.3M | 29.8M | 30.1M | 29.7M | 28.5M | 28.5M | 27.1M | 25.7M | 24.7M | 22.5M | 21.3M | 20M | 18.5M | 17.3M | 15.6M | 14.2M | 13M | 11.7M | 10.9M | 10.1M | 9.5M | 9M |
Stock-Based Compensation | 234.5M | 222.3M | 217.9M | 225.7M | 213.5M | 203.8M | 195.5M | 167.2M | 173.5M | 198.9M | 194.3M | 199.7M | 195M | 176M | 173.1M | 165.2M | 159.2M | 138.3M | 134.2M | 119.6M | 109.2M | 110.1M |
Other Working Capital | 128.4M | 156.2M | 97M | 116.7M | 177.9M | 76M | 39.7M | -95.6M | -42.7M | 108.3M | 112.1M | 184.6M | 125.4M | 79M | 97.4M | 87.9M | 55.1M | 35.7M | 47.6M | 20.9M | 41.4M | 33.4M |
Other Non-Cash Items | -70.2M | -66.9M | 19.5M | 21.2M | 58.4M | 124.3M | 173.8M | 136M | 159.1M | 40.9M | -46.9M | -17.9M | -61.9M | 58.8M | 44.5M | 23.1M | 48M | -24M | 800K | -251.5M | -252.7M | -265.6M |
Deferred Income Tax | 130.1M | 118M | 165.4M | 85.9M | -117.3M | -121.2M | -123.1M | -71.2M | -40.5M | -40.7M | -56.7M | -63.8M | -50.6M | -12.2M | 19.1M | 900K | -2.4M | 10.2M | 4.3M | 9M | 3.3M | -6.2M |
Change in Working Capital | -149.1M | -108.1M | -128.8M | -153.7M | 35.9M | -11.3M | -19.2M | -167.2M | -125.6M | 54.1M | 28.2M | 80.4M | 18.8M | -49.2M | -67.4M | -61M | -66.4M | -78.9M | 16.7M | 9.2M | 25M | 25.4M |
Operating Cash Flow | 898.1M | 863.7M | 782.7M | 636.8M | 567.3M | 529.9M | 595.4M | 476.4M | 530.4M | 645.4M | 389.9M | 409.4M | 296.2M | 254.7M | 339.4M | 200.6M | 163.6M | 128.7M | 256.5M | 341.2M | 259M | 274.7M |
Capital Expenditures | -27.7M | -32.4M | -34M | -43.7M | -38.6M | -37.7M | -38.2M | -36.3M | -35.8M | -31M | -28.3M | -24.7M | -15.4M | -17.4M | -16.5M | -23.6M | -31M | -26.5M | -23.4M | -19M | -13.7M | -14.1M |
Cash Acquisitions | -2.3B | 63.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.59B | -1.87B | -1.32B | -1.31B | -1.13B | -1.01B | -1.06B | -1.23B | -1.36B | -1.49B | -1.41B | -1.16B | -928.8M | -665.9M | -628.9M | -537M | -683M | -911.5M | -804.7M | -999.6M | -830M | -657.2M |
Sales Maturities Of Investments | 3.02B | 1.05B | 1.09B | 1.07B | 1.11B | 989.3M | 967.5M | 1.01B | 1.02B | 1.04B | 972.4M | 843.8M | 642M | 538.4M | 511M | 522.8M | 611.3M | 713.1M | 697.9M | 717M | 693.5M | 705.3M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -42.7M | -41M | -41M | -41M | 1.7M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -891.2M | -784.8M | -264.4M | -279.8M | -58.4M | -57.6M | -126.8M | -260.3M | -382.3M | -480M | -467.1M | -380.9M | -344.9M | -187.6M | -177.1M | -37.8M | -102.7M | -224.9M | -130.2M | -301.6M | -150.2M | 34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -279M | -279M | -279M | -279M | n/a | -100K | -100K | -100K | -100K |
Common Stock Repurchased | -66M | -71.7M | -167.7M | -467.7M | -467.7M | -450M | -300M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -65.1M | -55.7M | n/a | n/a | n/a | -308.8M | -308.8M | -308.8M | -308.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -186.9M | -184M | -184M |
Financial Cash Flow | 60.2M | -6.5M | -38.3M | -365.6M | -384.8M | -674.5M | -486.7M | -161.3M | -168.9M | 127M | 65.3M | 54.5M | 47.1M | -232.2M | -234.3M | -257.1M | -261M | 18.4M | 27.4M | -153.8M | -155.9M | -143.1M |
Net Cash Flow | 66.9M | 72.4M | 480M | -8.9M | 124.3M | -202.2M | -18.1M | 55.4M | -20.5M | 292.7M | -11.6M | 81.7M | -2.9M | -166.4M | -73.3M | -94.3M | -200.1M | -77.8M | 153.7M | -114.2M | -47.1M | 165.6M |
Free Cash Flow | 870.4M | 831.3M | 748.7M | 593.1M | 528.7M | 492.2M | 557.2M | 440.1M | 494.6M | 614.4M | 361.6M | 384.7M | 280.8M | 237.3M | 322.9M | 177M | 132.6M | 102.2M | 233.1M | 322.2M | 245.3M | 260.6M |
Adj. Free Cash Flow | 635.9M | 609M | 530.8M | 367.4M | 315.2M | 288.4M | 361.7M | 272.9M | 321.1M | 415.5M | 167.3M | 185M | 85.8M | 61.3M | 149.8M | 11.8M | -26.6M | -36.1M | 98.9M | 202.6M | 136.1M | 150.5M |
Maintenance CapEx | -10.3M | -2.5M | 4.16M | -639.27K | -639.27K | -639.27K | n/a | n/a | n/a | n/a | n/a | n/a | 3.4M | 3.4M | 3.4M | 2.55M | -1.85M | -6.15M | -10.65M | -13.82M | -12.83M | -8.53M |
Growth CapEx | -17.4M | -29.9M | -38.16M | -43.06M | -37.96M | -37.06M | -38.2M | -36.3M | -35.8M | -31M | -28.3M | -24.7M | -18.8M | -20.8M | -19.9M | -26.15M | -29.15M | -20.35M | -12.75M | -5.18M | -871.04K | -5.57M |
Owner Earnings | 887.8M | 861.2M | 786.86M | 636.16M | 566.66M | 529.26M | 595.4M | 476.4M | 530.4M | 645.4M | 389.9M | 409.4M | 299.6M | 258.1M | 342.8M | 203.15M | 161.75M | 122.55M | 245.85M | 327.38M | 246.17M | 266.17M |
Add to Watchlist
Select watchlists to add or remove NBIX